Is the lactobacillus effective against CVV recurrence: systematic review of clinical trials? Švitrigailė Grincevičienė1, Jonas Grincevičius1, Povilas Kavaliauskas2,

Slides:



Advertisements
Similar presentations
Randomized Controlled Trial
Advertisements

Introduction to Evidence Based Medicine Dr. Yaser Adi MD, MPH, MSc HTA Senior Researcher Sheikh Abdullah S BaHamdan’s Research Chair for EBHC-KT College.
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Does the use of antipyretics in children prolong febrile illness? David King Clinical Research Fellow 05/09/2013.
VITAMIN D AND MATERNAL HEALTH Studies linking vitamin D with maternal complications Claire K. Candelier The Midland Hotel, Manchester 17 th September 2013.
Esophageal Candidiasis in Patients with AIDS. Case 32-year-old male with AIDS CD4 50 cells/mm3 Reports severe pain and difficulty swallowing “It feels.
Hepatitis web study Hepatitis web study Telaprevir in Treatment Experienced GT-1 REALIZE (Study 216) Phase 3 Treatment Experienced Zeuzem S, et al. N Engl.
Hepatitis web study Hepatitis web study Sofosbuvir in Genotypes 2 or 3 VALENCE Trial Phase 3 Treatment Naïve and Treatment Experienced Zeuzem S, et al.
Hepatitis web study Hepatitis web study Peginterferon alfa-2a + RBV versus Interferon alfa-2a + RBV ACTG 5071 Phase 2 Treatment Naïve, Chronic HCV and.
Evidence-based Medicine Journal Club Khalid Bin Abdulrahman Director of Medical Education Center King Saud University.
Evidence-Based Practice for Pharmacy Y2 Pamela Corley, MLS, AHIP Joe Pozdol, MLIS Norris Medical Library 2003 Zonal Ave. Los Angeles, CA
Evidence-Based Nursing Practice: Literature Search
Asymptomatic UC patients on an immunomodulator with persistent moderate mucosal inflammation should either add a biologic or switch to a biologic William.
Hepatitis web study Hepatitis web study Interferon alfa-2b +/- Ribavirin for 24 or 48 weeks Phase 3 Treatment Naïve, Chronic HCV McHutchison JG, et al.
Oropharyngeal Candidiasis in Patients with AIDS
METHODS This evidenced-based literature review compares the use of GnRHa therapy and laparoscopic ablation with respect to symptom relief, recurrence of.
Reading Scientific Papers Shimae Soheilipour
The Library and The Center for Knowledge Management Evidence-Based Nursing Practice: Literature Search.
Introduction to Basic Science Emily L. Lowe, Ph.D. Microbiology, Immunology and Molecular Genetics UCLA.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Mucocutaneous Candidiasis Slide Set Prepared.
Which drugs?. Mode of action of antifungals ergosterol polyenes e.g. amphotericin B polyenes azoles e.g. fluconazole azoles nucleosides e.g. 5-flucytosine.
Searching beyond the RCT - looking for sibling studies on qualitative, economic and process research Faten Hamad and Christine Urquhart.
Evidence-Based Practice: Evidence-Based Practice: NUR 126 Denise Filiatrault Adopted from Curry College Division of Nursing Elizabeth Kudzma.
Finding Relevant Evidence
Experimental studies Jean-François Boivin 25 October 2010.
Class 15, 1st year Introdução à Medicina II 28th May 2010
Lenalidomide Maintenance Therapy in Multiple Myeloma: A Meta-Analysis of Randomized Trials Singh PP et al. Proc ASH 2013;Abstract 407.
OPPORTUNISTIC MYCOSES
1 How to find literature - A very short introduction - How to start smart Students IIC/IID Medical Library, August 2013.
BIBLE PAPER 26 AUG 2015 CANDIDA GLABRATA ESOPHAGITIS: ARE WE SEEING THE EMERGENCE OF A NEW AZOLE-RESISTANT PATHOGEN? WILSON A, DELPORT J, PONICH T. INT.
Corporate Collaborations 2015 Franco Vicariotto, MD Dep.of vulvovaginal disease.hospital V.Buzzi University of Milan PROBIOTICAL S.P.A. Italy GUNA S.P.A.
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Sandra Halliday, B.Sc., M.Sc., M.L.I.S. Health Sciences Librarian Bracken Library, Queen’s University.
Internet Resources PubMed/Clinical Queries PubMed/Filters Additional Resources.
By: Kristin Izzo Preceptors: Elizabeth Koustis, MS, RD Pamela Jessup, MS, RD WADE PARK NUTRITION CLINIC.
ANTIFUNGAL DRUGS PHARM 514 Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington
Managing Candidemia JEANNE FORRESTER, PHARMD, BCPS PGY2 INFECTIOUS DISEASES PHARMACY RESIDENT MEDICAL UNIVERSITY OF SOUTH CAROLINA.
Lactobacillus reuteri DSM for the management of infantile colic in breastfed infants A randomized, double-blind, placebo-controlled trial.
FIGURE 3. FOREST PLOT AFTER CONTROLLING FOR NETWORK INCONSISTENCY
A quick reference to literature searches
Systematic review of Present clinical reality
Symptom Control and Enhancing Functioning in Schizophrenia
How to read a paper D. Singh-Ranger.
Critical Appraisal of: Systematic Review: Bisphosphanates and Osteonecrosis of the Jaw Basil Al-Saigh August 2006.
EVIDENCE BASED MEDICINE
Process Indicators for Patient Navigation
Use of Probiotics in Larger Controlled Trials in Humans
Finding the Best Evidence in the Least Time
Volume 152, Issue 8, Pages e9 (June 2017)
کار گاه آموزشی مرور ساختار يافته و متاآناليز
David J.A. Jenkins et al. JACC 2018;71:
Volume 152, Issue 8, Pages e9 (June 2017)
Volume 152, Issue 8, Pages e9 (June 2017)
A presentation to: Meeting name Date
on EBSCOhost research databases
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
Module 4 Finding the Evidence: Individual Trials
Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and.
Module 6 Part B: Internet Resources
Treatments for Subacute Cough in Primary Care: Systematic Review and Meta-analyses of Randomized Clinical Trials Benjamin Speich, Anja Thomer, Soheila.
earching the best evidence
Preterm birth is the number one cause of neonatal mortality in the U.S. and with substantial cost burdens. If treatment of periodontal disease in pregnant.
The Research Question Background: Question:
Example of Information Extracted from an Article
Level of Evidence Lecture 4.
Volume 152, Issue 8, Pages e9 (June 2017)
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Trent Regional SAPC Conference 19 March 2019
Presentation transcript:

Is the lactobacillus effective against CVV recurrence: systematic review of clinical trials? Švitrigailė Grincevičienė1, Jonas Grincevičius1, Povilas Kavaliauskas2, Arūnas Savickas1, Jurga Bernatonienė1 1 Lithuanian University of Health Sciences, 2 Vilnius University Introduction High incidence rate of recurrence CVV. Azoles could have adverse drug reactions. Fluconazole – limited option. Probiotics are considered as supplemental treatment. The aim: to analyze the evidence of effectiveness of lactobacillus as supplemental option in prevention of recurrent CVV. Results Materials and Methods Study design: a systematic review of clinical trials. Definition: patients (without comorbidities) with 4 or more candida vaginitis during last year. Intervention: lactobacillus use for supplementary treatment. Outcome: symptoms free. Databases: MEDLINE via PubMed, CINAHL via EBSCO. Time: from 1992 up to June 1, 2015. Searching technique: PICO, citations search. Inclusion: RCT, observation - 6 months. Limitation of research: long-term of observation, rare outcomes, small number of RCT. Sample: 3 studies (141 patients) (3 RCT). . Conclusions Supplemental treatment of Lactobacillus could 3.9 times improve the odds of being symptom free from recurrence CVV for 6 months. Larger studies are necessary to confirm the results, because a meta-analysis of several small studies does not predict the results of a single large study. TERMS: (yeast infection OR candida vulvovaginitis OR Vulvovaginal Candidiases OR Vulvovaginal Candidiasis OR Moniliasis, Vulvovaginal OR vulvovaginal Moniliases OR Vulvovaginal Moniliasis OR Vaginitis, Monilial OR Monilial Vaginitides OR Monilial Vaginitis OR Vaginitides, Monilial OR candida OR albicans OR glabrata OR parapsilosis OR krusei) AND (lactobacillus OR probiotics OR probiotic OR l. reuteri OR l. rhamnosus OR l. casei OR l. acidophilus OR l. plantarium OR l. fermentum OR l. gasseri OR Streptococcus thermophilus OR L. delbrueckii bulgaricus) AND (Placebo OR no tretment OR Control Group OR Group, Control OR Groups, Control OR Supplemental OR treatment OR therapy OR use) AND (recurrent OR disease free OR symptom free OR symptoms free OR subjective OR Recurrence OR Recurrences OR Recrudescence OR Recrudescences OR Relapse OR Relapses) References Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351:876–883. Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. Fluconazole-Resistant Candida albicans Vulvovaginitis. Obstet Gynecol 2012;120:1407–14. Lewis JH, Zimmerman HJ, Benson GD, et al. Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology. 1984;86:503–513. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58:266–272.